company background image
VITR logo

Vitrolife OM:VITR Stock Report

Last Price

SEK 149.30

Market Cap

SEK 20.2b

7D

-3.9%

1Y

-19.1%

Updated

22 May, 2025

Data

Company Financials +

Vitrolife AB (publ)

OM:VITR Stock Report

Market Cap: SEK 20.2b

VITR Stock Overview

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. More details

VITR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance3/6
Financial Health4/6
Dividends0/6

Rewards

Trading at 37.3% below our estimate of its fair value

Earnings are forecast to grow 18.59% per year

Became profitable this year

Analysts in good agreement that stock price will rise by 62.4%

Risk Analysis

No risks detected for VITR from our risk checks.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Vitrolife AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vitrolife
Historical stock prices
Current Share PriceSEK 149.30
52 Week HighSEK 268.00
52 Week LowSEK 142.90
Beta1.83
1 Month Change-2.10%
3 Month Change-27.52%
1 Year Change-19.12%
3 Year Change-41.22%
5 Year Change-20.33%
Change since IPO2,002.82%

Recent News & Updates

Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Apr 25
Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Recent updates

Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Apr 25
Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Mar 13
Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Estimating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Feb 20
Estimating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 27
Is Vitrolife (STO:VITR) A Risky Investment?

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Aug 21
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Jul 20
Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth

Jul 18
Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

Apr 03
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Mar 07
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05
Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Jan 05
Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Dec 15
Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 06
Is Vitrolife (STO:VITR) A Risky Investment?

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Aug 25
An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Vitrolife (STO:VITR) Could Easily Take On More Debt

Aug 03
Vitrolife (STO:VITR) Could Easily Take On More Debt

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

May 26
Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

Is Vitrolife (STO:VITR) A Risky Investment?

Jan 23
Is Vitrolife (STO:VITR) A Risky Investment?

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Oct 18
Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Sep 09
Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Jul 07
Is Vitrolife (STO:VITR) A Risky Investment?

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

May 26
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Shareholder Returns

VITRSE BiotechsSE Market
7D-3.9%-2.1%-2.4%
1Y-19.1%-5.5%-5.8%

Return vs Industry: VITR underperformed the Swedish Biotechs industry which returned -0.9% over the past year.

Return vs Market: VITR underperformed the Swedish Market which returned -3.7% over the past year.

Price Volatility

Is VITR's price volatile compared to industry and market?
VITR volatility
VITR Average Weekly Movement6.1%
Biotechs Industry Average Movement9.9%
Market Average Movement6.8%
10% most volatile stocks in SE Market13.8%
10% least volatile stocks in SE Market4.2%

Stable Share Price: VITR has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: VITR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19891,150Bronwyn Brophy O´Connorwww.vitrolife.com

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp.

Vitrolife AB (publ) Fundamentals Summary

How do Vitrolife's earnings and revenue compare to its market cap?
VITR fundamental statistics
Market capSEK 20.22b
Earnings (TTM)SEK 498.00m
Revenue (TTM)SEK 3.61b
40.6x
P/E Ratio
5.6x
P/S Ratio

Is VITR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VITR income statement (TTM)
RevenueSEK 3.61b
Cost of RevenueSEK 1.47b
Gross ProfitSEK 2.14b
Other ExpensesSEK 1.64b
EarningsSEK 498.00m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 17, 2025

Earnings per share (EPS)3.68
Gross Margin59.34%
Net Profit Margin13.79%
Debt/Equity Ratio13.8%

How did VITR perform over the long term?

See historical performance and comparison

Dividends

0.7%
Current Dividend Yield
30%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 03:19
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vitrolife AB (publ) is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kallum TitchmarshBofA Global Research